John Mascarenhas, MD

Professor of Medicine (Hematology and Medical Oncology)
Director, Center of Excellence for Blood Cancers and Myeloid Disorders
Director, Adult Leukemia Program
Mount Sinai Tisch Cancer Center

John Mascarenhas, MD

View full profile

Related Videos

Ropeginterferon (BESREMI) for Polycytheia Vera Video

Ropeginterferon (BESREMI) for Polycytheia Vera

John Mascarenhas, MD, discusses findings from the ECLIPSE study.

Clinical Outcomes at 3 and 6 Months of Fedratinib Therapy Following Prior Ruxolitinib Failure for Myerlofibrosis: Real-World Assessment of Spleen, Symptoms, and Hematologic Response Video

Clinical Outcomes at 3 and 6 Months of Fedratinib Therapy Following Prior Ruxolitinib Failure for Myerlofibrosis: Real-World Assessment of Spleen, Symptoms, and Hematologic Response

Improvement in spleen and symptom burden with fedratinib therapy for patients with myelofibrosis